Denosumab-induced autoimmune hepatitis: Case report
- PMID: 38634089
- PMCID: PMC11021674
- DOI: 10.1002/ccr3.8736
Denosumab-induced autoimmune hepatitis: Case report
Abstract
This report described a patient not known to have a hepatic disease, found to have a drug-induced autoimmune hepatitis from denosumab. This is an unreported side effect, and here, we presented the possible predisposing factors and suggested monitoring parameters.
Keywords: autoimmune hepatitis; denosumab; drug‐induced hepatitis; hepatitis.
© 2024 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab.J Oncol Pharm Pract. 2023 Sep;29(6):1494-1497. doi: 10.1177/10781552231174593. Epub 2023 May 11. J Oncol Pharm Pract. 2023. PMID: 37170613
-
Severe hepatocytotoxicity linked to denosumab.Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):78-85. Eur Rev Med Pharmacol Sci. 2017. PMID: 28379592
-
Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report.J Med Case Rep. 2019 Apr 20;13(1):99. doi: 10.1186/s13256-019-2018-7. J Med Case Rep. 2019. PMID: 31003599 Free PMC article.
-
Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.Hepatology. 1997 Oct;26(4):1054-66. doi: 10.1002/hep.510260438. Hepatology. 1997. PMID: 9328334 Review.
-
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature.J Med Case Rep. 2022 Dec 16;16(1):473. doi: 10.1186/s13256-022-03695-y. J Med Case Rep. 2022. PMID: 36522673 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources